Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.

about

Glucocorticoid use and its association with skeletal health among U.S. adults with diabetes.

P2860

Q50195310-C090D7ED-ACD1-4827-83FC-7C76A62E0E8E

P2860

Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.

Item

http://www.wikidata.org/entity/Q36265141

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Undertreatment of osteoporosis ...... Medicare Part D drug coverage.

@ast

Undertreatment of osteoporosis ...... Medicare Part D drug coverage.

@en

type

Item

label

Undertreatment of osteoporosis ...... Medicare Part D drug coverage.

@ast

Undertreatment of osteoporosis ...... Medicare Part D drug coverage.

@en

prefLabel

Undertreatment of osteoporosis ...... Medicare Part D drug coverage.

@ast

Undertreatment of osteoporosis ...... Medicare Part D drug coverage.

@en

P1476

Undertreatment of osteoporosis ...... Medicare Part D drug coverage.

@en

P2093

Ankita Modi

http://www.w3.org/2001/XMLSchema#string

Anshu Shrestha

http://www.w3.org/2001/XMLSchema#string

Ethel S Siris

http://www.w3.org/2001/XMLSchema#string

Jingbo Yu

http://www.w3.org/2001/XMLSchema#string

John A Romley

http://www.w3.org/2001/XMLSchema#string

Katalin Bognar

http://www.w3.org/2001/XMLSchema#string

Mitch DeKoven

http://www.w3.org/2001/XMLSchema#string

P2860

Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?

Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates.

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis

The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study

Evaluation and management of osteoporosis following hospitalization for low-impact fracture.

Accident or osteoporosis?: Survey of community follow-up after low-trauma fracture

P304

1813-1824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CIA.S83488

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26604724

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

4639522

http://www.w3.org/2001/XMLSchema#string

Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.

about

P2860

P2860

Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932